FIELD: medicine.
SUBSTANCE: invention refers to medicine, namely to experimental surgery, and can be used to simulate critical ischemia of lower extremities in experimental animals – rats. A complex operative removal of a site of the main vessels including femoral, popliteal, anterior and posterior tibial arteries and veins, as well as a sciatic nerve is performed.
EFFECT: method enables modeling of critical ischemia of lower extremities in experimental animals due to complex surgical removal of a portion of major vessels including femoral, popliteal, anterior and posterior tibial arteries and veins, as well as sciatic nerve, which is the most approximate model to critical ischemia in the human in obliterating diseases of arteries of the lower extremities.
1 cl, 1 tbl, 1 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR PHARMACOLOGICAL CORRECTION OF EXPERIMENTAL CRITICAL SKELETAL MUSCLE ISCHEMIA WITH SIMVASTATIN | 2020 |
|
RU2726076C1 |
METHOD FOR PHARMACOLOGICAL CORRECTION OF EXPERIMENTAL CRITICAL SKELETAL MUSCLE ISCHEMIA WITH A COMBINATION OF SIMVASTATIN AND MONONUCLEAR FRACTION OF AUTOLOGOUS BONE MARROW | 2020 |
|
RU2735838C1 |
METHOD FOR PHARMACOLOGICAL CORRECTION OF EXPERIMENTAL CRITICAL SKELETAL MUSCLE ISCHEMIA WITH A COMBINATION OF SIMVASTATIN, UDENAFIL AND MONONUCLEAR FRACTION OF AUTOLOGOUS BONE MARROW | 2020 |
|
RU2726077C1 |
METHOD FOR PHARMACOLOGICAL CORRECTION OF EXPERIMENTAL CRITICAL SKELETAL MUSCLE ISCHEMIA WITH A COMBINATION OF SIMVASTATIN AND UDENAFIL | 2020 |
|
RU2727891C1 |
METHOD OF PHARMACOLOGICAL CORRECTION OF ISCHEMIA OF SKELETAL MUSCLE WITH RESVERATROL | 2012 |
|
RU2518965C1 |
METHOD FOR PHARMACOLOGICAL CORRECTION OF SCELETAL MUSCLE ISCHEMIA WITH MINOXIDIL | 2012 |
|
RU2497200C1 |
METHOD OF TREATING CHRONIC LIMB ISCHEMIA EXPERIMENTALLY | 2014 |
|
RU2556606C1 |
METHOD FOR PHARMACOLOGICAL CORRECTION OF SKELETAL MUSCLE ISCHEMIA WITH NICORANDYL | 2012 |
|
RU2507597C2 |
METHOD FOR STIMULATING NEOANGIOGENESIS IN ISCHEMIC SKELETAL MUSCLE | 2014 |
|
RU2547692C1 |
METHOD FOR PHARMACOLOGICAL CORRECTION OF SKELETAL MUSCLE ISCHEMIA WITH L-NORVALINE | 2012 |
|
RU2507596C1 |
Authors
Dates
2020-10-13—Published
2020-03-18—Filed